Cargando…
CTNNA3 genetic polymorphism may be a new genetic signal of type 2 diabetes in the Chinese Han population: a case control study
BACKGROUND: Type 2 Diabetes (T2D) is the result of a combination of genes and environment. The identified genetic loci can only explain part of T2D risk. Our study is aimed to explore the association between CTNNA3 single nucleotide polymorphisms (SNPs) and T2D risk. METHODS: We conducted a 'ca...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8556947/ https://www.ncbi.nlm.nih.gov/pubmed/34717601 http://dx.doi.org/10.1186/s12920-021-01105-8 |
_version_ | 1784592275479724032 |
---|---|
author | Zhang, Yunjun Zhou, Xiaoman Dai, Wanjuan Sun, Juan Lin, Mei Zhang, Yutian Ding, Yipeng |
author_facet | Zhang, Yunjun Zhou, Xiaoman Dai, Wanjuan Sun, Juan Lin, Mei Zhang, Yutian Ding, Yipeng |
author_sort | Zhang, Yunjun |
collection | PubMed |
description | BACKGROUND: Type 2 Diabetes (T2D) is the result of a combination of genes and environment. The identified genetic loci can only explain part of T2D risk. Our study is aimed to explore the association between CTNNA3 single nucleotide polymorphisms (SNPs) and T2D risk. METHODS: We conducted a 'case–control' study among 1002 Chinese Han participants. Four candidate SNPs of CTNNA3 were selected (rs10822745 C/T, rs7920624 A/T, rs2441727 A/G, rs7914287 A/G), and logistic regression analysis was used to evaluate the association between candidate SNPs and T2D risk. We used single factor analysis of variance to analyze the differences of clinical characteristics among different genotypes. In this study, haplotype analysis was conducted by plink1.07 and Haploview software and linkage disequilibrium (LD) was calculated. The interaction of candidate SNPs in T2D risk was evaluated by multi-factor dimensionality reduction (MDR). Finally, we conducted a false-positive report probability (FPRP) analysis to detect whether the significant findings were just chance or noteworthy observations. RESULTS: The results showed that CTNNA3-rs7914287 was a risk factor for T2D (‘T’: OR = 1.33, p = 0.003; ‘TT’: OR = 2.21, p = 0.001; ‘TT’ (recessive): OR = 2.09, p = 0.001; Log-additive: OR = 1.34, p = 0.003). The results of subgroup analysis showed that rs7914287 was significantly associated with the increased risk of T2D among participants who were older than 60 years, males, smoking, drinking, or BMI > 24. We also found that rs2441727 was associated with reducing the T2D risk among participants who were older than 60 years, smoking, or drinking. In addition, rs7914287 was associated with T2D patients with no retinal degeneration; rs10822745 and rs7920624 were associated with the course of T2D patients. High density lipoprotein levels had significant differences under different genotypes of rs10822745. Under the different genotypes of rs7914287, the levels of aspartate aminotransferase, alanine aminotransferase and gamma-glutamyltransferase were also significantly different. CONCLUSION: We found that CTNNA3 genetic polymorphisms can be used as a new genetic signal of T2D risk in Chinese Han population. Especially, CTNNA3-rs7914287 showed an outstanding and significant association with T2D risk in both overall analysis and subgroup analysis. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12920-021-01105-8. |
format | Online Article Text |
id | pubmed-8556947 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-85569472021-11-01 CTNNA3 genetic polymorphism may be a new genetic signal of type 2 diabetes in the Chinese Han population: a case control study Zhang, Yunjun Zhou, Xiaoman Dai, Wanjuan Sun, Juan Lin, Mei Zhang, Yutian Ding, Yipeng BMC Med Genomics Research BACKGROUND: Type 2 Diabetes (T2D) is the result of a combination of genes and environment. The identified genetic loci can only explain part of T2D risk. Our study is aimed to explore the association between CTNNA3 single nucleotide polymorphisms (SNPs) and T2D risk. METHODS: We conducted a 'case–control' study among 1002 Chinese Han participants. Four candidate SNPs of CTNNA3 were selected (rs10822745 C/T, rs7920624 A/T, rs2441727 A/G, rs7914287 A/G), and logistic regression analysis was used to evaluate the association between candidate SNPs and T2D risk. We used single factor analysis of variance to analyze the differences of clinical characteristics among different genotypes. In this study, haplotype analysis was conducted by plink1.07 and Haploview software and linkage disequilibrium (LD) was calculated. The interaction of candidate SNPs in T2D risk was evaluated by multi-factor dimensionality reduction (MDR). Finally, we conducted a false-positive report probability (FPRP) analysis to detect whether the significant findings were just chance or noteworthy observations. RESULTS: The results showed that CTNNA3-rs7914287 was a risk factor for T2D (‘T’: OR = 1.33, p = 0.003; ‘TT’: OR = 2.21, p = 0.001; ‘TT’ (recessive): OR = 2.09, p = 0.001; Log-additive: OR = 1.34, p = 0.003). The results of subgroup analysis showed that rs7914287 was significantly associated with the increased risk of T2D among participants who were older than 60 years, males, smoking, drinking, or BMI > 24. We also found that rs2441727 was associated with reducing the T2D risk among participants who were older than 60 years, smoking, or drinking. In addition, rs7914287 was associated with T2D patients with no retinal degeneration; rs10822745 and rs7920624 were associated with the course of T2D patients. High density lipoprotein levels had significant differences under different genotypes of rs10822745. Under the different genotypes of rs7914287, the levels of aspartate aminotransferase, alanine aminotransferase and gamma-glutamyltransferase were also significantly different. CONCLUSION: We found that CTNNA3 genetic polymorphisms can be used as a new genetic signal of T2D risk in Chinese Han population. Especially, CTNNA3-rs7914287 showed an outstanding and significant association with T2D risk in both overall analysis and subgroup analysis. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12920-021-01105-8. BioMed Central 2021-10-30 /pmc/articles/PMC8556947/ /pubmed/34717601 http://dx.doi.org/10.1186/s12920-021-01105-8 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Zhang, Yunjun Zhou, Xiaoman Dai, Wanjuan Sun, Juan Lin, Mei Zhang, Yutian Ding, Yipeng CTNNA3 genetic polymorphism may be a new genetic signal of type 2 diabetes in the Chinese Han population: a case control study |
title | CTNNA3 genetic polymorphism may be a new genetic signal of type 2 diabetes in the Chinese Han population: a case control study |
title_full | CTNNA3 genetic polymorphism may be a new genetic signal of type 2 diabetes in the Chinese Han population: a case control study |
title_fullStr | CTNNA3 genetic polymorphism may be a new genetic signal of type 2 diabetes in the Chinese Han population: a case control study |
title_full_unstemmed | CTNNA3 genetic polymorphism may be a new genetic signal of type 2 diabetes in the Chinese Han population: a case control study |
title_short | CTNNA3 genetic polymorphism may be a new genetic signal of type 2 diabetes in the Chinese Han population: a case control study |
title_sort | ctnna3 genetic polymorphism may be a new genetic signal of type 2 diabetes in the chinese han population: a case control study |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8556947/ https://www.ncbi.nlm.nih.gov/pubmed/34717601 http://dx.doi.org/10.1186/s12920-021-01105-8 |
work_keys_str_mv | AT zhangyunjun ctnna3geneticpolymorphismmaybeanewgeneticsignaloftype2diabetesinthechinesehanpopulationacasecontrolstudy AT zhouxiaoman ctnna3geneticpolymorphismmaybeanewgeneticsignaloftype2diabetesinthechinesehanpopulationacasecontrolstudy AT daiwanjuan ctnna3geneticpolymorphismmaybeanewgeneticsignaloftype2diabetesinthechinesehanpopulationacasecontrolstudy AT sunjuan ctnna3geneticpolymorphismmaybeanewgeneticsignaloftype2diabetesinthechinesehanpopulationacasecontrolstudy AT linmei ctnna3geneticpolymorphismmaybeanewgeneticsignaloftype2diabetesinthechinesehanpopulationacasecontrolstudy AT zhangyutian ctnna3geneticpolymorphismmaybeanewgeneticsignaloftype2diabetesinthechinesehanpopulationacasecontrolstudy AT dingyipeng ctnna3geneticpolymorphismmaybeanewgeneticsignaloftype2diabetesinthechinesehanpopulationacasecontrolstudy |